Details

Autor(en) / Beteiligte

• Corona, Angela
• Di Leva, Francesco Saverio
• Thierry, Sylvain
• Pescatori, Luca
• Cuzzucoli Crucitti, Giuliana
• Subra, Frederic
• Delelis, Olivier
• Esposito, Francesca
• Rigogliuso, Giuseppe
• Costi, Roberta
• Cosconati, Sandro
• Novellino, Ettore
• Di Santo, Roberto
• Tramontano, Enzo

Titel

Identification of highly conserved residues involved in inhibition of HIV-1 RNase H function by Diketo acid derivatives

Ist Teil von

• Antimicrobial agents and chemotherapy, 2014-10, Vol.58 (10), p.6101-6110

Ort / Verlag

United States: American Society for Microbiology

Erscheinungsjahr

2014

Quelle

MEDLINE

Beschreibungen/Notizen

• HIV-1 reverse transcriptase (RT)-associated RNase H activity is an essential function in viral genome retrotranscription. RNase H is a promising drug target for which no inhibitor is available for therapy. Diketo acid (DKA) derivatives are active site Mg(2+)-binding inhibitors of both HIV-1 RNase H and integrase (IN) activities. To investigate the DKA binding site of RNase H and the mechanism of action, six couples of ester and acid DKAs, derived from 6-[1-(4-fluorophenyl)methyl-1H-pyrrol-2-yl)]-2,4-dioxo-5-hexenoic acid ethyl ester (RDS1643), were synthesized and tested on both RNase H and IN functions. Most of the ester derivatives showed selectivity for HIV-1 RNase H versus IN, while acids inhibited both functions. Molecular modeling and site-directed mutagenesis studies on the RNase H domain demonstrated different binding poses for ester and acid DKAs and proved that DKAs interact with residues (R448, N474, Q475, Y501, and R557) involved not in the catalytic motif but in highly conserved portions of the RNase H primer grip motif. The ester derivative RDS1759 selectively inhibited RNase H activity and viral replication in the low micromolar range, making contacts with residues Q475, N474, and Y501. Quantitative PCR studies and fluorescence-activated cell sorting (FACS) analyses showed that RDS1759 selectively inhibited reverse transcription in cell-based assays. Overall, we provide the first demonstration that RNase H inhibition by DKAs is due not only to their chelating properties but also to specific interactions with highly conserved amino acid residues in the RNase H domain, leading to effective targeting of HIV retrotranscription in cells and hence offering important insights for the rational design of RNase H inhibitors.